TABLE 5.
Predictors of locoregional recurrence (LRR) in patients with ductal carcinoma-in situ treated with mastectomy (n = 810)
| Characteristics | Patients with LRR, n (%) | Patients without LRR, n (%) | p value |
|---|---|---|---|
| All patients | 8 (1.0) | 802 (99.0) | |
| Race | |||
| White | 7 (87.5) | 593 (74.0) | |
| African American | 1 (12.5) | 84 (10.5) | |
| Hispanic | 0 (0) | 66 (8.2) | |
| Asian/Pacific Islander | 0 (0) | 46 (5.7) | |
| Other | 0 (0) | 13 (1.6) | 0.831 |
| Age, years, median (range) | 53 (20–88) | 47.5 (41–62) | 0.363 |
| Menopausal statusa | |||
| Premenopausal | 5 (62.5) | 274 (34.2) | |
| Postmenopausal | 3 (37.5) | 526 (65.8) | 0.096 |
| Bilateral breast cancer at diagnosis | |||
| Yes | 1 (12.5) | 99 (12.5) | |
| No | 7 (87.5) | 703 (87.6) | 0.997 |
| Initial presentationb | |||
| Clinical | 1 (12.5) | 187 (23.5) | |
| Radiological | 7 (87.5) | 611 (76.5) | 0.464 |
| Largest recorded mammographic dimension, cm, median (range)c | 2.5 (0.7–14) | 3.5 (0.3–20) | 0.816 |
| Skin-sparing mastectomy | |||
| Yes | 7 (87.5) | 462 (57.5) | |
| No | 1 (12.5) | 340 (42.5) | 0.088 |
| Immediate breast reconstruction | |||
| Yes | 7 (87.5) | 527 (65.8) | |
| No | 1 (12.5) | 275 (34.3) | 0.196 |
| Contralateral prophylactic mastectomy | |||
| Yes | 1 (12.5) | 132 (16.4) | |
| No | 7 (87.5) | 670 (83.6) | 0.765 |
| Largest recorded pathologic lesion size, cm, median (range)d | 1.2 (0.5–8.0) | 2.2 (0.02–19) | 0.659 |
| Nuclear gradee | |||
| I or II | 2 (25.0) | 349 (44.1) | |
| III | 6 (75.0) | 442 (55.9) | 0.278 |
| Margin status | |||
| ≤1 mm | 3 (37.5) | 56 (7.0) | |
| 1.1–2.9 mm | 1 (12.5) | 34 (4.2) | |
| ≥3 mm | 4 (50.0) | 712 (88.8) | 0.002 |
| Multicentricf | |||
| Yes | 5 (100.0) | 242 (38.4) | |
| No | 0 (0) | 389 (61.7) | 0.005 |
| Multifocalg | |||
| Yes | 5 (100.0) | 233 (38.2) | |
| No | 0 (0) | 377 (61.8) | 0.005 |
| Comedoh | |||
| Yes | 2 (25.0) | 250 (32.6) | |
| No | 6 (75.0) | 517 (67.4) | 0.648 |
| Necrosis | |||
| Yes | 6 (75.0) | 378 (47.1) | |
| No | 2 (25.0) | 424 (52.9) | 0.115 |
Two patients were perimenopausal
Not available for four patients
Not available for 423 patients
Not available for 181 patients
Not available for 11 patients
Not available for 174 patients
Not available for 195 patients
Not available for 35 patients